NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Overview
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Discounted Cash Flow
DCF Analysis for NAMSW.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.86
Current Fair Value
$2.86
↓ 84.7% Downside
Overvalued by 84.7% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison